Gilead’s remdesivir scores emergency FDA nod in COVID-19 days after big data reveal
Days after U.S. officials and others reported the first positive controlled data for Gilead’s remdesivir in COVID-19, the FDA has given the drug an emergency use authorization. President Donald Trump and Gilead CEO Daniel O’Day made the announcement Friday afternoon at the White House, according to CNBC’s Meg Tirrell. An FDA fact sheet on the… Read More »